BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 29987824)

  • 21. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
    Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.
    Okada K; Tanaka Y; Bernstein M; Zhang W; Patterson GA; Botney MD
    Am J Pathol; 1997 Oct; 151(4):1019-25. PubMed ID: 9327735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
    Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.
    Miyauchi T; Yorikane R; Sakai S; Sakurai T; Okada M; Nishikibe M; Yano M; Yamaguchi I; Sugishita Y; Goto K
    Circ Res; 1993 Nov; 73(5):887-97. PubMed ID: 8403258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP; Hikasa Y
    Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMGB1 promotes the development of pulmonary arterial hypertension in rats.
    Sadamura-Takenaka Y; Ito T; Noma S; Oyama Y; Yamada S; Kawahara K; Inoue H; Maruyama I
    PLoS One; 2014; 9(7):e102482. PubMed ID: 25032709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.
    Hessel MH; Steendijk P; den Adel B; Schutte CI; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2424-30. PubMed ID: 16731643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats.
    Umar S; Nadadur RD; Li J; Maltese F; Partownavid P; van der Laarse A; Eghbali M
    Hypertension; 2011 Sep; 58(3):512-8. PubMed ID: 21747043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
    Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension.
    Brown MB; Neves E; Long G; Graber J; Gladish B; Wiseman A; Owens M; Fisher AJ; Presson RG; Petrache I; Kline J; Lahm T
    Am J Physiol Regul Integr Comp Physiol; 2017 Feb; 312(2):R197-R210. PubMed ID: 27784688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.